SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor

Fletcher, P; Harman, S; Azijn, H; Armanasco, N; Manlow, P; Perumal, D; de Bethune, MP; Nuttall, J; Romano, J; Shattock, R (2009) Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 53 (2). 487 - 495 (9). ISSN 0066-4804 https://doi.org/10.1128/AAC.01156-08
SGUL Authors: Shattock, Robin John

Full text not available from this repository.

Item Type: Article
Additional Information: PubMed ID: 19029331
Keywords: Anti-HIV Agents, Cells, Cultured, Cervix Uteri, Dose-Response Relationship, Drug, Female, HIV Infections, HIV-1, Humans, Luciferases, Macrophages, Organ Culture Techniques, Pyrimidines, Reverse Transcriptase Inhibitors, T-Lymphocytes, Science & Technology, Life Sciences & Biomedicine, Microbiology, Pharmacology & Pharmacy, HUMAN CERVICAL TISSUE, HIV DRUG CANDIDATES, EXPERIENCED HIV-1-INFECTED PATIENTS, PLACEBO-CONTROLLED TRIAL, ELASTOMER VAGINAL RINGS, TMC125 ETRAVIRINE, GEL FORMULATION, DOUBLE-BLIND, TRANSMISSION, EVOLUTION
Journal or Publication Title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
ISSN: 0066-4804
Related URLs:
Dates:
DateEvent
1 February 2009Published
Web of Science ID: WOS:000262646500017
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
URI: http://openaccess.sgul.ac.uk/id/eprint/279
Publisher's version: https://doi.org/10.1128/AAC.01156-08

Actions (login required)

Edit Item Edit Item